Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis

The genetic polymorphism of apolipoprotein E (apoE) is associated with the age of onset and relative risk of Alzheimer's disease (AD). In contrast to apoE3, the wild type allele, apoE4 confers an increased risk of late-onset AD. We demonstrate that the β-amyloid peptide isoforms Aβ (1–28), Aβ (1–40), and Aβ (1–43) compete for the cellular metabolism of apoE3 and apoE4 containing β-very low density lipoproteins. An antibody raised against Aβ (1–28) cross-reacted with recombinant apoE. Epitope mapping revealed positive amino acid clusters as common epitopes of Aβ (13 through 17; HHQKL) and apoE (residues 144 through 148; LRKRL), both regions known to be heparin binding domains. Aβ in which amino acids 13 through 17 (HHQKL) were replaced by glycine (GGQGL) failed to compete with the cellular uptake of apoE enriched βVLDL. These observations indicate that Aβ and apoE are taken up into cells by a common pathway involving heparan sulfate proteoglycans. —Winkler, K., H. Scharnagl, U. Tisljar, H. Hoschützky, I. Friedrich, M. M. Hoffman, M. Hüttinger, H. Wieland, and W. März. Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. J. Lipid Res. 1999. 40: 447–455.

Abstract licence: CC BY-NC-ND

60 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.